FRX.TO Live signals | Maximize Profits with Getagraph.com

Live Chart Being Loaded With Signals

Commentary (19 Apr 2024 @ 11:27):

Stats
Today's Volume	400.00
Average Volume	343.00
Market Cap	347.42M
EPS	$0 ( 2024-03-26 )
Next earnings date	( $0 ) 2024-05-08
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-15.45
ATR14	$0 (0.00%)

Fennec Pharmaceuticals Correlation

10 Most Positive Correlations

10 Most Negative Correlations

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Fennec Pharmaceuticals Financials

Annual	2023
Revenue:	$21.25M
Gross Profit:	$19.99M (94.08 %)
EPS:	$-0.600

Q4	2023
Revenue:	$9.74M
Gross Profit:	$9.05M (92.96 %)
EPS:	$0

Q3	2023
Revenue:	$6.52M
Gross Profit:	$6.18M (94.92 %)
EPS:	$-0.0706

Q2	2023
Revenue:	$3.33M
Gross Profit:	$3.18M (95.55 %)
EPS:	$-0.210

Financial Reports:

No articles found.

Fennec Pharmaceuticals

Fennec Pharmaceuticals Inc. operates as a biopharmaceutical company. Its product candidate in the clinical stage of development is PEDMARK, a formulation of sodium thiosulfate for the prevention of platinum-induced ototoxicity in pediatric cancer patients. The company was formerly known as Adherex Technologies Inc. and changed its name to Fennec Pharmaceuticals Inc. in September 2014. Fennec Pharmaceuticals Inc. was incorporated in 1996 and is based in Research Triangle Park, North Carolina.